BeStock  
Stocks › Biotechnology › BLTE

Belite Bio BLTE

US equityMarket cap rank #2018Biotechnology
$127.38 −$23.64 (-15.65%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $127.38 0.00%
Open$129.00
Prev close$151.02
Day range$120.00 – $135.07
Volume1.04M
Market cap$5.17B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership66.2%+0.00 pts vs. prior quarter
Institutions holding95+2 vs. prior quarter
Insider trades (recent)10 buys / 26 sellsNet selling
Short interest3.43% of floatDays to cover 10.0 · as of 30 Oct 2026
Short-sale volume share11.8%5-day average of daily volume

Short-sale volume as % of daily volume

5%16%27%38%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$13.90M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$15.0MSuper+$1.1MBig+$902.7KMid+$4.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 56.2% of shares outstanding.

Largest holders

  • Lin BioScience, Inc.42.45%
  • Darwin Global Management Limited7.64%
  • Paradigm Biocapital Advisors LP3.06%
  • RTW Investments, LP1.78%
  • Millennium Management LLC1.23%
  • Maverick Capital, Ltd.0.98%
  • Eventide Asset Management, LLC0.97%
  • Deerfield Management Company, L.P.0.89%

By investor type

  • Public Company43.57%
  • Hedge Fund18.70%
  • Mutual Fund2.62%
  • Individual/Insider1.42%
  • VC/PE Fund0.77%
  • Family Office/Trust0.27%
  • Private Company0.25%
  • Government Pension Fund0.06%

Reported short interest has risen from 2.77% to 3.43% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Candriam, Société En Commandite Par Actions Mutual Fund 2026/Q3 +62,842 0.2%
Alberta Investment Management Corporation Government Pension Fund 2026/Q3 +24,000 0.1%
Barclays PLC Public Company 2026/Q3 +23,252 0.1%
Patient Square Capital, LP VC/PE Fund 2026/Q3 +21,700 0.3%
Maverick Capital, Ltd. Hedge Fund 2026/Q3 +396,311 1.0%
Logos Global Management, L.P. Hedge Fund 2026/Q3 +250,000 0.6%
Citadel Advisors LLC Hedge Fund 2026/Q3 +184,160 0.5%
Bank of America Corporation Public Company 2026/Q3 +119,885 0.3%
Paradigm Biocapital Advisors LP Hedge Fund 2026/Q3 +118,093 3.1%
Affinity Asset Advisors, LLC Hedge Fund 2026/Q3 +100,000 0.4%
Morgan Stanley Public Company 2026/Q3 +75,589 0.6%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +60,679 0.4%
Jane Street Group, LLC Private Company 2026/Q3 +53,579 0.2%
Deerfield Management Company, L.P. Hedge Fund 2026/Q3 +53,186 0.9%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +51,186 0.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
28 Oct 2026 Hao-Yuan Chuang Chief Financial Officer Other Acquisition +5,000 – 210,264
28 Oct 2026 Yu-Hsin Lin Chairman of the Board of Directors & CEO Other Acquisition +5,000 – 187,949
30 Sep 2026 Hendrik Scholl Chief Medical Officer Private Disposition -500 $170.02 14,500
23 Sep 2026 Wan-Shan Chen Director Derivative Exercise and Retained +13,796 $0.44 37,259
7 Sep 2026 Hao-Yuan Chuang Chief Financial Officer Automatic Disposition -67,395 $198.05 26,038
7 Sep 2026 Yu-Hsin Lin Chairman of the Board of Directors & CEO Automatic Disposition -100,435 $198.09 70,134
11 Aug 2026 Hao-Yuan Chuang Chief Financial Officer Automatic Disposition -367 $180.57 93,433
11 Aug 2026 Yu-Hsin Lin Chairman of the Board of Directors & CEO Automatic Disposition -365 $180.57 170,569
17 Jun 2026 Hendrik Scholl Chief Medical Officer Private Disposition -10,000 $147.11 15,000
15 Jun 2026 Hendrik Scholl Chief Medical Officer Private Disposition -10,000 $145.02 25,000
6 May 2026 Nathan Mata Chief Scientific Officer Automatic Disposition -666 $155.25 –
5 May 2026 Nathan Mata Chief Scientific Officer Automatic Disposition -1,000 $156.00 666
4 May 2026 Nathan Mata Chief Scientific Officer Automatic Disposition -1,000 $158.11 1,666
3 May 2026 Nathan Mata Chief Scientific Officer Automatic Disposition -1,000 $157.49 2,666
30 Apr 2026 Nathan Mata Chief Scientific Officer Automatic Disposition -1,000 $160.00 3,666
29 Apr 2026 Nathan Mata Chief Scientific Officer Automatic Disposition -1,000 $158.15 4,666
28 Apr 2026 Nathan Mata Chief Scientific Officer Automatic Disposition -1,000 $158.19 5,666
27 Apr 2026 Nathan Mata Chief Scientific Officer Automatic Disposition -1,000 $162.14 6,666
26 Apr 2026 Nathan Mata Chief Scientific Officer Automatic Disposition -1,000 $164.07 7,666
23 Apr 2026 Nathan Mata Chief Scientific Officer Automatic Disposition -1,000 $162.53 8,666

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 1,380,466 3.4% 10.0
15 Oct 2026 1,267,440 3.1% 7.1
30 Sep 2026 1,057,536 2.6% 7.3
15 Sep 2026 1,050,466 2.6% 3.8
31 Aug 2026 1,049,817 2.6% 7.4
14 Aug 2026 1,116,380 2.8% 5.8

Discussion

No comments yet — be the first to weigh in on BLTE.

Sign in to join the discussion.

Scroll to Top